These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 32430207)

  • 21. Evaluation of Cycle Threshold, Toxin Concentration, and Clinical Characteristics of Clostridioides difficile Infection in Patients with Discordant Diagnostic Test Results.
    Shah MD; Balada-Llasat JM; Coe K; Reed E; Sandlund J; Pancholi P
    J Clin Microbiol; 2020 Apr; 58(5):. PubMed ID: 32051264
    [No Abstract]   [Full Text] [Related]  

  • 22. Is Clostridioides difficile toxins detection necessary when the glutamate dehydrogenase enzyme is detected?
    García-Fuentes JF; Torres-Murillo BJ; Aguilar-Orozco G; González É; Mosqueda JL; Macías AE; Álvarez JA
    Gac Med Mex; 2021; 157(1):107-109. PubMed ID: 34125803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of laboratory tests for detection for Clostridioides difficile: A multicenter prospective study in Japan.
    Senoh M; Kato H; Honda H; Fukuda T; Tagashira Y; Horiuchi H; Chiba H; Suzuki D; Hosokawa N; Kitazono H; Norisue Y; Kume H; Mori N; Morikawa H; Kashiwagura S; Higuchi A; Kato H; Nakamura M; Ishiguro S; Morita S; Ishikawa H; Watanabe T; Kojima K; Yokomaku I; Bando T; Toimoto K; Moriya K; Kasahara K; Kitada S; Ogawa J; Saito H; Tominaga H; Shimizu Y; Masumoto F; Tadera K; Yoshida J; Kikuchi T; Yoshikawa I; Watanabe T; Honda M; Yokote K; Toyokawa T; Miyazato H; Nakama M; Mahe C; Reske K; Olsen MA; Dubberke ER
    Anaerobe; 2019 Dec; 60():102107. PubMed ID: 31647977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-Effectiveness Analysis of Four Common Diagnostic Methods for Clostridioides difficile Infection.
    Xuan S; Zangwill KM; Ni W; Ma J; Hay JW
    J Gen Intern Med; 2020 Apr; 35(4):1102-1110. PubMed ID: 32016703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Description of antibiotic treatment in adults tested for Clostridioides difficile infection: a single-center case-control study.
    Kim MH; Kim YC; Kim JL; Park YS; Kim H
    BMC Infect Dis; 2022 Jan; 22(1):104. PubMed ID: 35093016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Risk Factors for Clostridium difficile Infection Based on Immunochromatography Testing and Toxigenic Culture Assay.
    Ohshima T; Osaki T; Yamamoto Y; Asai S; Miyachi H; Kamiya S
    J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30232129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of toxigenic Clostridioides [Clostridium] difficile: Usefulness of two commercially available enzyme immunoassays and a PCR assay on stool samples and stool isolates.
    Legaria MC; Rollet R; Di Martino A; Castello L; Barberis C; Rossetti MA; Guardati MC; Fernández Canigia L; Carloni G; Litterio M; Rocchi M; Anchart EG; Trejo FM; Minnaard J; Klajn D; Predari SC
    Rev Argent Microbiol; 2018; 50(1):36-44. PubMed ID: 28988901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Epidemiology of Clostridioides difficile Infections in Children.
    Perumalsamy S; Riley TV
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S34-S40. PubMed ID: 34791401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laboratory diagnosis of Clostridium difficile infection: Comparison of Techlab C. diff Quik Chek Complete, Xpert C. difficile, and multistep algorithmic approach.
    Seo JY; Jeong JH; Kim KH; Ahn JY; Park PW; Seo YH
    J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 28177534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current Diagnostic and Treatment Approach of Clostridioides difficile Infection.
    Yunita B; Fauzi A
    Acta Med Indones; 2023 Apr; 55(2):231-238. PubMed ID: 37524596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Standardisation and validation of an in-house quantitative real-time polymerase chain reaction (qPCR) assay for the diagnosis of Clostridioides difficile infection.
    Maestri AC; Raboni SM; Cogo LL; Rossi MV; Nogueira KS
    J Microbiol Methods; 2022 Feb; 193():106399. PubMed ID: 34958834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cytotoxic synergy between Clostridioides difficile toxin B and proinflammatory cytokines: an unholy alliance favoring the onset of Clostridioides difficile infection and relapses.
    Bassotti G; Marchegiani A; Marconi P; Fettucciari K
    Microbiologyopen; 2020 Aug; 9(8):e1061. PubMed ID: 32657021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.
    Guh AY; Hatfield KM; Winston LG; Martin B; Johnston H; Brousseau G; Farley MM; Wilson L; Perlmutter R; Phipps EC; Dumyati GK; Nelson D; Hatwar T; Kainer MA; Paulick AL; Karlsson M; Gerding DN; McDonald LC
    Clin Infect Dis; 2019 Oct; 69(10):1667-1674. PubMed ID: 30615074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discordant
    Lenggenhager L; Zanella MC; Poncet A; Kaiser L; Schrenzel J
    BMJ Open; 2020 Sep; 10(9):e036342. PubMed ID: 32928850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Community-Associated Clostridioides difficile Infection in Children: A Review of Recent Literature.
    Adams DJ; Barone JB; Nylund CM
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S22-S26. PubMed ID: 34791398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Australasian Society for Infectious Diseases guidelines for the diagnosis and treatment of Clostridium difficile infection.
    Cheng AC; Ferguson JK; Richards MJ; Robson JM; Gilbert GL; McGregor A; Roberts S; Korman TM; Riley TV;
    Med J Aust; 2011 Apr; 194(7):353-8. PubMed ID: 21470086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consensus on the prevention, diagnosis, and treatment of Clostridium difficile infection.
    Abreu Y Abreu AT; Velarde-Ruiz Velasco JA; Zavala-Solares MR; Remes-Troche JM; Carmona-Sánchez RI; Aldana-Ledesma JM; Camacho-Ortiz A; Contreras-Omaña R; Díaz-Seoane R; Elizondo-Vázquez CT; Garza-González E; Grajales-Figueroa G; Gómez-Escudero O; Jacobo-Karam JS; Morales-Arámbula M; Olivares-Guzmán LO; Sifuentes-Osornio J; Siu-Moguel AG; Soto-Solís R; Valdovinos-García LR; Valdovinos-Díaz MA; Vázquez-Elizondo G; Lazo-de la Vega Jasso SA
    Rev Gastroenterol Mex (Engl Ed); 2019; 84(2):204-219. PubMed ID: 30987771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Review of Clostridioides difficile Infection and Antibiotic-Associated Diarrhea.
    Abad CLR; Safdar N
    Gastroenterol Clin North Am; 2021 Jun; 50(2):323-340. PubMed ID: 34024444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Environmental shedding of toxigenic Clostridioides difficile by asymptomatic carriers: A prospective observational study.
    Gilboa M; Houri-Levi E; Cohen C; Tal I; Rubin C; Feld-Simon O; Brom A; Eden-Friedman Y; Segal S; Rahav G; Regev-Yochay G;
    Clin Microbiol Infect; 2020 Aug; 26(8):1052-1057. PubMed ID: 31904567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of antibiotic to induce Clostridioides difficile-susceptibility and infectious strain in a mouse model of Clostridioides difficile infection and recurrence.
    Castro-Córdova P; Díaz-Yáñez F; Muñoz-Miralles J; Gil F; Paredes-Sabja D
    Anaerobe; 2020 Apr; 62():102149. PubMed ID: 31940467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.